Jing-Wen Xu Selected Research

Vaccines

1/2021

Dalbavancin binds ACE2 to block its interaction with SARS-CoV-2 spike protein and is effective in inhibiting SARS-CoV-2 infection in animal models.

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.

Realize the full power of the drug-disease research graph!

Jing-Wen Xu Research Topics

Disease

3	Neoplasms (Cancer) 01/2018 - 12/2014
2	COVID-19 04/2021 - 01/2021
2	Pancreatic Neoplasms (Pancreatic Cancer) 01/2020 - 01/2018
1	Wounds and Injuries (Trauma) 01/2021
1	Carcinoma (Carcinomatosis) 12/2018
1	Hepatocellular Carcinoma (Hepatoma) 12/2014
1	Liver Neoplasms (Liver Cancer) 12/2014
1	Heart Failure 05/2014
1	Periodontitis 07/2002
1	Bone Resorption 07/2002
1	Alveolar Bone Loss 07/2002

Drug/Important Bio-Agent (IBA)

3	Pharmaceutical PreparationsIBA 01/2021 - 07/2002
2	gamma-sitosterol (beta-sitosterol)IBA 01/2020 - 01/2018
2	Gemcitabine FDA Link 01/2020 - 01/2018
1	Antiviral Agents (Antivirals)IBA 04/2021
1	dalbavancinIBA 01/2021
1	VaccinesIBA 01/2021
1	SARS-CoV-2 spike proteinIBA 01/2021
1	BromidesIBA 12/2018
1	Paclitaxel (Taxol)FDA LinkGeneric 12/2018
1	polymethacrylic acid (PMAA)IBA 05/2016
1	MicellesIBA 05/2016
1	TubulinIBA 12/2014
1	5- (3- hydroxy- 4- methoxyphenyl)- 4- (3,4,5- trimethoxyphenyl)- 3H- 1,2- dithiol- 3- oneIBA 12/2014
1	Matrix Metalloproteinases (MMPs)IBA 07/2002
1	TetracyclinesIBA 07/2002
1	EndotoxinsIBA 07/2002
1	Doxycycline (Periostat)FDA LinkGeneric 07/2002
1	goat lung surfactant extractIBA 07/2002
1	GelatinasesIBA 07/2002
1	GelatinIBA 07/2002

Therapy/Procedure

1	Patient Readmission 05/2014